 |
  |
||||||||
 |
|||||||||
|
|||||||||
 |
|||||||||
 |
|||||||||
|
|
 |
|
|
Investors and Media |
|
|
|
Stock Quote & Chart |
|
|
|
SEC Filings |
|
|
|
Fundamentals |
|
|
|
Press Releases |
|
|
|
Recent InvestorPresentations |
|
|
|
Analyst Coverage |
|
|
|
Info Requests |
|
|
|
Email Alerts |
|
|
|
|
 |
|||||||
|
|
|
|||||
|
|||||||
| Corporate Overview
Corporate Profile ISTA Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved products for serious diseases and conditions of the eye. Our strategic plan is to transform from a development stage organization to a specialty pharmaceutical company with a primary focus on ophthalmology. Listed Security ISTA Common Transfer Agent U.S. Stock Transfer Corporation 1745 Gardena Avenue Glendale, CA 91204-2991 Phone (818) 502-1404 Corporate Counsel Robert C. Funsten Stradling Yocca Carlson & Rauth 660 Newport Center Drive, Ste. 1600 Newport Beach, CA 92660 Phone (949) 725-4000 Fax (949) 823-5204 Independent Accountants Ernst & Young, LLP 501 West Broadway Suite 1100 San Diego, CA 92101 Phone 619-235-5000 |
|||||||
|
|||||||
| © 2007 ISTA Pharmaceuticals. All Rights Reserved. Disclaimer | Privacy Policy |